ANZALONE CHRISTOPHER RICHARD (Chief Executive Officer) sold 0.3% of their position (13.19K shares) of ARROWHEAD PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $871.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/5/2026ACC: 0001423029-26-000001
DirectorOfficer· Chief Executive Officer
Since Aug 2018
-13.19K
Net shares
Net seller
$871.7K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
13.19K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−7.42K
Price / share
$65.88
Trade value
$488.57K
% of position
0.2%
1/2/2026
3.81M→3.80M
Common Stock
Direct
Shares
−5.77K
Price / share
$66.39
Trade value
$383.14K
% of position
0.2%
1/2/2026
3.80M→3.79M
Total
Net shares
−13.19K
Net value
-$871.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | S · Sale | −7.42K | $65.88 | $488.57K | 0.2% | 3.81M | 3.80M |
| Common Stock Direct | 1/2/2026 | S · Sale | −5.77K | $66.39 | $383.14K | 0.2% | 3.80M | 3.79M |
| Total | −13.19K | -$871.70K | ||||||
Derivative Transactions0
No derivative transactions reported